HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists
Hospital for Special Surgery COVID-19 Antibody Serology Among Anesthesiologists and Surgeons 2020
1 other identifier
interventional
143
1 country
1
Brief Summary
The goal of this study is to understand the infectious exposure of SARS-coronavirus 2 (SARS-CoV2) among surgeons and anesthesiologists and to correlate this status with self-reported indices of COVID-19 illness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 5, 2020
CompletedFirst Submitted
Initial submission to the registry
May 8, 2020
CompletedFirst Posted
Study publicly available on registry
May 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 16, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 4, 2020
CompletedResults Posted
Study results publicly available
January 3, 2024
CompletedJanuary 3, 2024
March 1, 2023
1 month
May 8, 2020
March 29, 2022
March 21, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Participants With SARS-CoV-2 IgG Antibodies
Prevalence of SARS-CoV-2 IgG antibodies by serology testing in participants at the time of study enrollment or 3 months later
Serology Test #1 (Study Enrollment) and Test #2 (3 months apart)
Secondary Outcomes (6)
Differences in Sex Between IgG Antibody-positive vs. Negative Participants
Survey completed before or on day of serology testing asking about information from January 1, 2020 to May 5, 2020
Number of Asymptomatic Participants With Positive Antibody Serology
Serology Test #1 (Study Enrollment) and Serology Test #2 (3 months apart)
Percentage of Antibody-positive Participants Who Subsequently Develop COVID-19
Serology Test #1 (Study Enrollment) and Serology Test #2 (3 months apart)
Differences in Race Between IgG Antibody-positive vs. Negative Participants
Survey completed before or on day of serology testing asking about information from January 1, 2020 to May 5, 2020
Differences in Average Number of Adults in Household Between IgG Antibody-positive vs. Negative Participants
Survey completed before or on day of serology testing asking about information from January 1, 2020 to May 5, 2020
- +1 more secondary outcomes
Other Outcomes (1)
Participants Who Were Eligible for in Plasma Donation
Serology Test #1 (Study Enrollment) and Test #2 (3 months apart)
Interventions
Participants will have SARS-CoV2 serum antibody testing performed twice within 4 months of each other.
Eligibility Criteria
You may qualify if:
- Accredited to practice at HSS
- All anesthesiology and surgery faculty
- All anesthesia and orthopedic surgery fellows
- All orthopedic surgery residents
You may not qualify if:
- Refusal to participate in either of the interventions at either of the timepoints of interest
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital for Special Surgery
New York, New York, 10021, United States
Results Point of Contact
- Title
- Dr. Ellen M. Soffin
- Organization
- Hospital for Special Surgery
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 8, 2020
First Posted
May 15, 2020
Study Start
May 5, 2020
Primary Completion
June 16, 2020
Study Completion
September 4, 2020
Last Updated
January 3, 2024
Results First Posted
January 3, 2024
Record last verified: 2023-03